Lublin A - Search Results

1

Teriflunomide Inhibits JCPyV Infection and Spread in Glial Cells and Choroid Plexus Epithelial Cells.

O'Hara BA, Gee GV, Haley SA, Morris-Love J, Nyblade C, Nieves C, Hanson BA, Dang X, Turner TJ, Chavin JM, Lublin A, Koralnik IJ, Atwood WJ. O'Hara BA, et al. Among authors: lublin a. Int J Mol Sci. 2021 Sep 10;22(18):9809. doi: 10.3390/ijms22189809. Int J Mol Sci. 2021. PMID: 34575975 Free PMC article.

2

Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study.

Miller AE, Olsson TP, Wolinsky JS, Comi G, Kappos L, Hu X, Xu X, Lublin AL, Truffinet P, Chavin J, Delhay JL, Benamor M, Purvis A, Freedman MS; TOWER investigators. Miller AE, et al. Among authors: lublin al. Mult Scler Relat Disord. 2020 Nov;46:102438. doi: 10.1016/j.msard.2020.102438. Epub 2020 Aug 1. Mult Scler Relat Disord. 2020. PMID: 32911306 Clinical Trial.

3

Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide.

Tornatore C, Wiendl H, Lublin AL, Geertsen SS, Chavin J, Truffinet P, Bar-Or A. Tornatore C, et al. Among authors: lublin al. Front Neurol. 2022 Feb 28;13:828616. doi: 10.3389/fneur.2022.828616. eCollection 2022. Front Neurol. 2022. PMID: 35295832 Free PMC article. Review.

4

Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.

Gandy S, Simon AJ, Steele JW, Lublin AL, Lah JJ, Walker LC, Levey AI, Krafft GA, Levy E, Checler F, Glabe C, Bilker WB, Abel T, Schmeidler J, Ehrlich ME. Gandy S, et al. Among authors: lublin al. Ann Neurol. 2010 Aug;68(2):220-30. doi: 10.1002/ana.22052. Ann Neurol. 2010. PMID: 20641005 Free PMC article.

5

Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's Disease.

Lublin AL, Gandy S. Lublin AL, et al. Mt Sinai J Med. 2010 Jan-Feb;77(1):43-9. doi: 10.1002/msj.20160. Mt Sinai J Med. 2010. PMID: 20101723 Free PMC article. Review.

6

[No title available]

[No authors listed] [No authors listed] PMID: 23646059

7

FDA-approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on cbp and protect against proteotoxicity.

Lublin A, Isoda F, Patel H, Yen K, Nguyen L, Hajje D, Schwartz M, Mobbs C. Lublin A, et al. PLoS One. 2011;6(11):e27762. doi: 10.1371/journal.pone.0027762. Epub 2011 Nov 16. PLoS One. 2011. PMID: 22114686 Free PMC article.

8

SOD isoforms play no role in lifespan in ad lib or dietary restricted conditions, but mutational inactivation of SOD-1 reduces life extension by cold.

Yen K, Patel HB, Lublin AL, Mobbs CV. Yen K, et al. Mech Ageing Dev. 2009 Mar;130(3):173-8. doi: 10.1016/j.mad.2008.11.003. Epub 2008 Nov 19. Mech Ageing Dev. 2009. PMID: 19059428

9

Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.

Knight EM, Kim SH, Kottwitz JC, Hatami A, Albay R, Suzuki A, Lublin A, Alberini CM, Klein WL, Szabo P, Relkin NR, Ehrlich M, Glabe CG, Gandy S, Steele JW. Knight EM, et al. Among authors: lublin a. Neurol Neuroimmunol Neuroinflamm. 2016 May 10;3(3):e237. doi: 10.1212/NXI.0000000000000237. eCollection 2016 Jun. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27218118 Free PMC article.

10

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity.

Lublin AL, Link CD. Lublin AL, et al. Drug Discov Today Technol. 2013 Spring;10(1):e115-e119. doi: 10.1016/j.ddtec.2012.02.002. Drug Discov Today Technol. 2013. PMID: 24050239 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters